ÈËÉú¾ÍÊDz©ÊÖ»ú°æ

ÈËÉú¾ÍÊDz©ÊÖ»ú°æ

  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-10-13   ä¯ÀÀ´ÎÊý£º3470´Î
    ½üÈÕ£¬£¬£¬£¬£¬È«Çò¹æÄ£×î´ó¡¢Ó°ÏìÁ¦×î¹ãµÄ·ÅÉäÖ×ÁöѧѧÊõÊ¢»á——µÚ67½ìÃÀ¹ú·ÅÉäÖ×Áöѧ»á£¨ASTRO£©Äê»áÔÚÃÀ¹ú¾É½ðɽ¡³ÁÕÙ¿ª£¬£¬£¬£¬£¬»ã¾ÛÁ˳¬1ÍòÃûÀ´×ÔÊÀ½ç¸÷µØµÄ¶¥¼â·ÅÁÆ×¨¼Ò¡¢Ñ§Õß¡£¡£¡£¡£¡£ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©£¨301015.SZ£©Í¶×ÊÆóÒµ——·ÅÉä±í¿ÆÁìÓò´´ÐÂٮٮÕßZAP SurgicalЯȫÇòµ±ÏȵÄÄÔÖ×Áö¾«×¼·ÅÁÆ»úеÈËZAP-X®»ðÐÇÖÛ·ÅÉä±í¿Æ»úеÈ˳õ´ÎÁÁÏà´ó»á£¬£¬£¬£¬£¬È«ÃæÕ¹Ê¾ÁËZAP-XµÄ×îм¼ÊõÍ»ÆÆÓëÁÙ´²³É¾Í¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-09-28   ä¯ÀÀ´ÎÊý£º3388´Î
    2025Äê9ÔÂ27ÈÕ£¬£¬£¬£¬£¬“2025ÖйúÐÄÔà´ó»á´´ÐÂÓëת»¯ÂÛ̳ôß¾©Î÷´´ÐÂҩе²úÒµ·¢Õ¹´ó»á”ÔÚ±±¾©½øÐС£¡£¡£¡£¡£±¾´Î´ó»áÓɹú¶ÈÐÄѪ¹Ü²¡ÖÐÐĽáºÏ±±¾©Êм¶Óйز¿ÃźÍÃÅÍ·¹µÇøµ±¾Ö¹²Í¬½øÐУ¬£¬£¬£¬£¬Éî¶ÈЭͬ“Õþ²úѧÑнð·þÓÔȫÉí·Ö£¬£¬£¬£¬£¬Îª“ÖйúÐĹȔ½¨Éè¼°±±¾©Ò½Ò©½¡È«²úÒµ¸ßÖÊÁ¿·¢Õ¹Äý¾Û¶¯ÄÜ¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-09-23   ä¯ÀÀ´ÎÊý£º4418´Î
    ½üÈÕ£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©£¨¹ÉƱ´úÂ룺301015.SZ£©ÆìÏ“ȫÇò²¹¸Æ×¨¼Ò”µÏÇÉÆ·ÅÆÍƳöÒºÌå°±ÌǸƲúÆ·ËÙ½Ú®£¬£¬£¬£¬£¬¾Û½¹ÐÂÖÐÄêÈËȺ¹Ø½ÚÓë¹Ç÷À½¡È«ÖÎÀíµÄÖ÷ÌâÐèÒª£¬£¬£¬£¬£¬ÒÔ´´ÐÂÒºÌå¼ÁÐÍ£¬£¬£¬£¬£¬ÎªÏû·ÑÕß´øÀ´È«ÐµĹؽÚÑø»¤Ñ¡Ôñ¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-09-12   ä¯ÀÀ´ÎÊý£º3553´Î
    2025Äê9ÔÂ12ÈÕ£¬£¬£¬£¬£¬Í¨ÁÉÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©”£¬£¬£¬£¬£¬¹ÉƱ´úÂ룺301015.SZ£©ÓëÌì½ò¼ÃÀ¤Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“¼ÃÀ¤Ò½Ò©”£©Ç©¶¨Õ½ÊõºÏ×÷ºÍ̸£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©Õ½ÊõͶ×ʼÃÀ¤Ò½Ò©£¬£¬£¬£¬£¬Äâ³ÖÓÐÆä24%¹ÉȨ£¬£¬£¬£¬£¬½ø¶øËø¶¨¼ÃÀ¤Ò½Ò©ÆìÏÂÓÃÓÚÒ½ÖηÎÏËά»¯1Àà´´ÐÂÒ©µÄËùÓÐȨÀû¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬£¬¹«Ë¾¶Ô¼ÃÀ¤Ò½Ò©³ÖÓеÄËùÓвúÆ·µÄÈ«Çò»¯ºÏÎïȨÀûÏíÓÐÒ»ÖÂǰÌáÏÂÓÅÏȲɰìȨ¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-08-07   ä¯ÀÀ´ÎÊý£º3835´Î
    ½üÈÕ£¬£¬£¬£¬£¬Í¬ÐÄÒ½ÁÆÃÀ¹úÈ«×Ê×Ó¹«Ë¾BrioHealth Solutions, Inc.°ä·¢¹«Ë¾×ÔÖ÷Ñз¢µÄÈ«´ÅÐü¸¡×óÐÄÊÒ¸¨ÖúϵͳBrioVADÔڳɹ¦ÊµÏÖÃÀ¹úINNOVATEÁÙ´²ÊÔÑ鰲ȫÐԽ׶Σ¨Safety Phase£©×êÑк󣬣¬£¬£¬£¬Õýʽ»ñµÃÃÀ¹úʳƷҩƷ¼à¶½ÖÎÀí¾Ö£¨The Food and Drug Administration, FDA£©ºË×¼½øÈëÈ·Ö¤ÐԽ׶Σ¨Pivotal Phase£©×êÑУ¬£¬£¬£¬£¬FDAÔ޳ɽ«ÁÙ´²×êÑÐÖÐÐÄÀ©´óµ½60¼Ò£¬£¬£¬£¬£¬²¢¿ÉÀÛ¼ÆÈë×é780ÃûÊÜÊÔÕߣ¨Ô̺¬°²È«ÐÔ½×¶ÎÊÜÊÔÕߣ©¡£¡£¡£¡£¡£
·µ»Ø¶¥²¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿